How high is Dean Xia Ningshao of Xiamen University? Is his academic achievement his own?

Education is secondary education. As for academic performance, now it is mostly teamwork. It is very difficult for a person to complete a large and complex project, but this cannot deny his achievements. Personally, I think professionals are beyond doubt. As can be seen from his resume, he has gradually become an elite in the industry.

Resume:

0 1 1.6- Dean of School of Public Health, Xiamen University

2005. 12- director of national infectious disease diagnostic reagent and vaccine engineering technology research center (Xiamen university)

July 2003-Director of Fujian Medical Molecular Virology Research Center (Xiamen University)

1995. 12- School of Life Sciences, Xiamen University, Associate Research Fellow (1995), Professor (2002), Doctoral Supervisor (2003), "Minjiang Scholar" distinguished professor (2007).

1996.3-6 Visiting Scholar, Department of Microbiology, School of Medicine, University of Hong Kong.

1990.12-1995.9 Visiting scholar, Institute of Virology, Chinese Academy of Preventive Medicine.

1981.9-1995.12 Department of Infectious Diseases, Loudi District People's Hospital, Hunan Province, resident (1983), attending physician (1992), deputy chief physician (/.

Main research results:

Two neutralizing epitopes of hepatitis E virus were identified for the first time in the world, and hepatitis E virus particles were expressed in Escherichia coli for the first time. Three international invention patents have been applied for related achievements, and the first, second and third phase clinical trials of the declared national first-class new drug "recombinant hepatitis E vaccine" have been completed.

The developed HIV recombinant antigen and the third generation diagnostic kit are at the same level as the best reagents in the world at present. This product has occupied 20% of the national AIDS testing reagent market for two consecutive years, and its total sales volume ranks first in the country. In 2002, the kit was listed as "national key new product" by the Ministry of Science and Technology and other six ministries, and was selected as "industrialization demonstration project" by the State Planning Commission in 2003.

In cooperation with the University of Hong Kong and Shantou University, the world's first specific rapid diagnostic kit for highly pathogenic avian influenza was developed in June 2004. In 2005, the project won the national science and technology research plan and special funds for the prevention and treatment of highly pathogenic avian influenza.